2595 Share Price Performance
HK$0
-42.10 (-100.00%)
Price HK$0
Share Pricen/a
GenFleet Therapeutics (Shanghai) Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
2595 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
GenFleet Therapeutics (Shanghai) Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 24, 2026
- -2.50
- 80.86%
- -479.17%
- -3.0%
About 2595
- Founded
- 2017
- Employees
- 94
- CEO
- WebsiteView website
GenFleet Therapeutics (Shanghai) Inc. operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases. The company’s products include GFH925, help for the treatment of advanced non-small cell lung cancer, and GFH375, an orally bioavailable small molecule inhibitor of Kirsten rat sarcoma (KRAS) G12C. The company was incorporated in 2017 and is based in Shanghai, China.
